Symple Surgical Inc. Completes Series A Common Stock Financing

In a tough investment climate for medical device companies, Symple Surgical Inc. announced today that it has completed a Series A Common Stock financing, totaling approximately $1.9 million to fund its novel microwave catheter technology platform.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
“Hypertension is a worldwide medical and economic burden. Renal sympathetic denervation is a unique therapy that has demonstrated benefit in patients that are not well treated with medical therapy alone." Dr. Gary M. Ansel, MD, FACC

Menlo Park, CA (PRWEB) December 05, 2013

Symple Surgical is developing a therapeutic microwave energy device for renal sympathetic denervation, to effectively modulate hyperactive sympathetic nerve signals.

  •     Renal sympathetic denervation is a novel therapy that addresses severe hypertension and other chronic diseases.
  •     The sympathetic nerves located along the renal artery wall play a critical role in controlling blood pressure. When overactive these nerves contribute to Cardiovascular Hypertension.
  •     Renal sympathetic denervation has been demonstrated to reduce blood pressure in patients who are not adequately treated by pharmacological and other medical therapies .

“Symple Surgical is committed to developing a unique device which is safe and effective for treating patients with resistant Hypertension, easy to use for the physician, and provides targeted therapy without damaging healthy tissue,” stated Randy Preston, Chief Operating Officer at Symple Surgical. “Initial pre-clinical testing has validated our core concepts and we will continue to refine our technology as we work towards a First-in-Man study by mid-2014.”

About Symple Surgical Inc.
Symple Surgical, Inc. is a privately-held company with engineering and product development offices in Menlo Park, CA. Symple Surgical is focused on developing a medical device to help millions of patients living with resistant hypertension through renal sympathetic denervation by delivering microwave energy at the location of the sympathetic nerves while minimizing thermal exposure to non-targeted areas.

Two proven medical device entrepreneurs, Daniel J. Kasprzyk and Randy Preston, founded Symple Surgical. With 25 years in the medical device industry Mr. Kasprzyk has executive experience in startup and multinational business platform companies and holds numerous patents in the device and equipment space. Mr. Preston’s experience includes 10 years international business development and project management in the interventional medical device field. He is uniquely positioned to lead the product development team as they refine and launch the novel Symple Surgical microwave device platform.

For more information:
Randy Preston, Chief Operating Officer
(415) 686-1284


Contact

  • Daniel Kasprzyk
    Symple Surgical Inc.
    +1 (650) 316-5764
    Email
  • Randy Preston
    Symple Surgical Inc
    (415) 686-1284
    Email

Attachments

Symple Surgical, renal sympathetic denervation, hypertension Download pdf

Symple Surgical Inc. Completes Series A Common Stock Financing